Author

Bao-Chau Vo

OpenAlex ID: A5113981461

Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion

2021 · Ahmad A. Aref, Ingrid U. Scott, et al. · JAMA Ophthalmology · 14

Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial

2023 · Steven M. Kymes, Neal L. Oden, et al. · JAMA Ophthalmology · 10

High-Dose Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury

2026 · Christian Stoppe, Aileen Hill, et al. · JAMA · 7

Baseline Characteristics and Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion

2022 · Ingrid U. Scott, Neal L. Oden, et al. · JAMA Ophthalmology · 6

Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition Is Associated With Individual Exposure but Not Community-Level Transmission

2022 · DeAnna J Friedman-Klabanoff, Meagan C Fitzpatrick, et al. · The Journal of Infectious Diseases · 4

Works count: 5

Citation count: 41

H-index: 4

I10-index: 2